Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AZN

AstraZeneca

$38.45

-0.53 (-1.36%)

, NVS

Novartis

$81.82

-0.3 (-0.37%)

08:24
08/16/18
08/16
08:24
08/16/18
08:24
Downgrade
AstraZeneca, Novartis, Roche, GlaxoSmithKline rating change  »

AstraZeneca downgraded to…

AZN

AstraZeneca

$38.45

-0.53 (-1.36%)

NVS

Novartis

$81.82

-0.3 (-0.37%)

RHHBY

Roche

$0.00

(0.00%)

GSK

GlaxoSmithKline

$40.45

0.66 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 25

    Aug

  • 27

    Aug

Wednesday
TLRY

Tilray

$28.90

4.75 (19.67%)

, STZ

Constellation Brands, also tag STZ.B

$207.56

-14.21 (-6.41%)

13:36
08/15/18
08/15
13:36
08/15/18
13:36
Hot Stocks
Citron sees Tilray getting 'support' after Constellation bets big in cannabis »

In a report published…

TLRY

Tilray

$28.90

4.75 (19.67%)

STZ

Constellation Brands, also tag STZ.B

$207.56

-14.21 (-6.41%)

STZ.B

Constellation Brands

$212.44

-8.54 (-3.86%)

CGC

Canopy Growth

$31.36

6.74 (27.38%)

NVS

Novartis

$81.77

-0.35 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Aug

  • 27

    Aug

  • 28

    Aug

  • 28

    Oct

Tuesday
NVS

Novartis

$82.46

0.34 (0.41%)

05:20
08/14/18
08/14
05:20
08/14/18
05:20
Hot Stocks
Novartis appoints Dr. Klaus Moosmayer as Chief Ethics Risk & Compliance Officer »

Novartis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 27

    Aug

Monday
REGN

Regeneron

$368.77

-3.55 (-0.95%)

, NVS

Novartis

$82.12

-1.14 (-1.37%)

09:38
08/13/18
08/13
09:38
08/13/18
09:38
Recommendations
Regeneron, Novartis analyst commentary at Piper Jaffray »

Regeneron should be…

REGN

Regeneron

$368.77

-3.55 (-0.95%)

NVS

Novartis

$82.12

-1.14 (-1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 27

    Aug

  • 20

    Oct

  • 28

    Oct

Over a week ago
ALDR

Alder Biopharmaceuticals

$19.15

0.15 (0.79%)

, AMGN

Amgen

$197.62

-0.36 (-0.18%)

07:30
08/07/18
08/07
07:30
08/07/18
07:30
Initiation
Alder Biopharmaceuticals, Amgen, Novartis, Eli Lilly, Teva initiated at Stifel »

Alder Biopharmaceuticals…

ALDR

Alder Biopharmaceuticals

$19.15

0.15 (0.79%)

AMGN

Amgen

$197.62

-0.36 (-0.18%)

NVS

Novartis

$83.49

0.17 (0.20%)

LLY

Eli Lilly

$102.00

1.4 (1.39%)

TEVA

Teva

$22.11

-0.065 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 10

    Sep

  • 16

    Sep

CLLS

Cellectis

$28.93

1.24 (4.48%)

, NVS

Novartis

$84.08

0.38 (0.45%)

16:44
08/02/18
08/02
16:44
08/02/18
16:44
Hot Stocks
Cellectis names Stefan Scherer deputy CMO »

Cellectis (CLLS)…

CLLS

Cellectis

$28.93

1.24 (4.48%)

NVS

Novartis

$84.08

0.38 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPHT

Ophthotech

$2.49

0.08 (3.32%)

, NVS

Novartis

$83.92

0.13 (0.16%)

07:17
08/01/18
08/01
07:17
08/01/18
07:17
Earnings
Ophthotech reports Q2 EPS (37c), two estimates (39c) »

Ophthotech (OPHT) said it…

OPHT

Ophthotech

$2.49

0.08 (3.32%)

NVS

Novartis

$83.92

0.13 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

NVS

Novartis

$83.79

0.295 (0.35%)

16:35
07/30/18
07/30
16:35
07/30/18
16:35
Earnings
Novartis announces EC approves Aimovig for the prevention of migraine in adults »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$83.25

0.32 (0.39%)

08:58
07/27/18
07/27
08:58
07/27/18
08:58
Hot Stocks
Sandoz receives European Commission approval for biosimilar Hyrimoz »

Sandoz, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$83.25

0.32 (0.39%)

08:29
07/27/18
07/27
08:29
07/27/18
08:29
Hot Stocks
Novartis says CHMP adopts positive opinion for combination Tafinlar + Mekinist »

Novartis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.